Covid-19 shots that are yet to get regulatory approval, according to people familiar with the matter, as the country pushes scientific boundaries in the race for a viable immunization.China National Biotec Group Co., or CNBG, a subsidiary of state-owned Sinopharm Group Co., is in talks with the Chinese government about giving students headed abroad to study its experimental vaccines, said the people, who asked not to be identified as they’re not authorized to speak publicly.
Various government agencies are still working on the plan and no final decision has been made, the people said.The two shots being developed by CNBG -- which are still in the final, third phase of testing -- were authorized for emergency use in China and have already.